Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Inclusion Criteria7

• Diagnosis of stage III or IV ovarian epithelial cancer and enrolled on Gynecologic Oncology Group (GOG)-0136 and a GOG front-line platinum/taxol chemotherapy trial (GOG-0114, GOG-132, GOG-0158, or GOG-0162)
• Must have fixed and paraffin-embedded tissue from primary surgery available from 1 of the following sources:
• Patients enrolled on GOG-0136 and a GOG front-line platinum/taxol chemotherapy trial(GOG-0114, GOG-0132, GOG-0158, and GOG-0162)
• Patients who have had either optimal or suboptimal cytoreductive surgery
• Patients for whom adequate demographic data, including major prognostic factors and follow-up information, were collected
• Evaluable patients must have had measurable or nonmeasurable disease
• Demographic and follow-up data available